Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2003-09-05
2009-08-25
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009100, C424S009200, C424S093100, C424S093400, C424S184100, C424S278100, C424S282100, C435S243000, C435S252100, C435S253200
Reexamination Certificate
active
07579009
ABSTRACT:
An immune modulator composition and/or pharmaceutical composition comprising a whole cell of a bacterium from the generaRhodococcus, Gordonia, Nocardia, Dietzia, TsukamurellaandNocardioides, wherein said immune modulator composition in use modifies a cellular immune response.
REFERENCES:
patent: 4599310 (1986-07-01), Matson et al.
patent: 5759992 (1998-06-01), Platt
patent: WO 98/39025 (1998-09-01), None
patent: WO 99/05304 (1999-02-01), None
patent: WO 02/32455 (2002-04-01), None
patent: WO 03/101399 (2003-12-01), None
Kang et al., “Th1 and Th2 Cytokine Responses to Academic Stress,”Research in Nursing&Health, vol. 24, p. 245-257 (2001).
Manabe et al., “Naturally Attenuated, Orally AdministeredMycobacterium microtias a Tuberculosis Vaccine Is Better than SubcutaneousMycobacterium bovisBCG.”Infection and Immunity, vol. 79, No. 3, p. 1566-1570 (2002).
Sharpe et al., “Single Oral Immunization with Replication Deficient Recombinant Adenovirus Elicits Long-Lived Transgene-Specific Cellular and Humoral Immune Response.”Virology, 293, p. 210-216 (2002).
Prescott et al., “Assessment of the immunogenic potential ofRhodococcus equivirulence associated protein (VapA) in mice,”Veterinary Medicine, vol. 56, pp. 213-225 (1997).
Takai et al., “Live virulentRhodococcus equi, rather than killed or avirulent, elicits protective immunity toR. equiinfection in mice,”FEMS Immunology and Medical Microbiology, vol. 24, pp. 1-9 (1999).
Yarkoni & Rapp, “Immunotherapy of Guinea pigs with a transplanted hepatoma: comparison of intralesionary injected emulsions containing heat-killedNocardia rubra, Mycobacterium bovis(BCG) andMycobacterium phlei,” Oncology, vol. 39, pp. 314-318 (1982).
Chambers et al., “Association of bovine papillomavirus with equine sarcoid,”J. Gen. Virol., vol. 84, pp. 1055-1062 (2003).
Nasir et al., “Screening for bovine papillomavirus in peripheral blood cells of donkeys with and without sarcoids,”Res. Vet. Sci., vol. 63, pp. 289-290 (1997).
NCIMB search results at http://www.ncimb.com/results.php?parent=culture.
Ikeda-Fugital et al., “Possible existence of a novel amphipathic immunostimulator in the phenol-water extracts ofMycobacteriaceae,” Microbiol. Immunol., Vo. 31(4), pp. 289-311 (1987).
Bottasso Oscar Adelmo
McIntyre Graham
Stanford Cynthia Ann
Stanford John Lawson
Steptoe & Johnson LLP
Swartz Rodney P.
University College London
LandOfFree
Whole bacterial cells as immune modulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Whole bacterial cells as immune modulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Whole bacterial cells as immune modulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4118579